KR970015583A - (S) -β-하이드록시-γ-부티로락톤의 제조방법 - Google Patents
(S) -β-하이드록시-γ-부티로락톤의 제조방법 Download PDFInfo
- Publication number
- KR970015583A KR970015583A KR1019960029667A KR19960029667A KR970015583A KR 970015583 A KR970015583 A KR 970015583A KR 1019960029667 A KR1019960029667 A KR 1019960029667A KR 19960029667 A KR19960029667 A KR 19960029667A KR 970015583 A KR970015583 A KR 970015583A
- Authority
- KR
- South Korea
- Prior art keywords
- hydroxy
- butyrolactone
- solvent
- structural formula
- following structural
- Prior art date
Links
- 229930188620 butyrolactone Natural products 0.000 title 1
- YEJRWHAVMIAJKC-UHFFFAOYSA-N gamma-butyrolactone Natural products O=C1CCCO1 YEJRWHAVMIAJKC-UHFFFAOYSA-N 0.000 title 1
- 238000000034 method Methods 0.000 claims abstract 6
- FUDDLSHBRSNCBV-VKHMYHEASA-N (4s)-4-hydroxyoxolan-2-one Chemical compound O[C@@H]1COC(=O)C1 FUDDLSHBRSNCBV-VKHMYHEASA-N 0.000 claims abstract 4
- FUDDLSHBRSNCBV-UHFFFAOYSA-N (+)-(R)-3-hydroxytetrahydrofuranone Natural products OC1COC(=O)C1 FUDDLSHBRSNCBV-UHFFFAOYSA-N 0.000 claims abstract 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims 3
- 239000002904 solvent Substances 0.000 claims 3
- PHIQHXFUZVPYII-LURJTMIESA-N (S)-carnitine Chemical compound C[N+](C)(C)C[C@@H](O)CC([O-])=O PHIQHXFUZVPYII-LURJTMIESA-N 0.000 claims 2
- 150000001450 anions Chemical class 0.000 claims 1
- 239000012442 inert solvent Substances 0.000 claims 1
- 239000012046 mixed solvent Substances 0.000 claims 1
- 238000010992 reflux Methods 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/32—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/32—Oxygen atoms
- C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Furan Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Seasonings (AREA)
Abstract
본 발명은 (S)-β-하이드록시-γ-부티로락톤의 제조방법에 관한 것으로서, 더욱 상세하기로는 라세미 혼합물의 분리방법에 의해 (R)-카르니틴을 제조하는 공정에서 얻어지는 값싼 폐부산물을 사용하고 몇몇 유기합성공정을 이용하여 광범위한 중간체 화합물로 사용되고 있는 (S)-β-하이드록시-γ-부티로락톤을 제조하는 방법에 관한 것이다.
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
Claims (5)
- 다음 반응식에 의해 (S)-카르니틴을 직접 전환시켜 다음 구조식(Ⅰ)로 표시되는 (S)-β-하이드록시-γ부티로락톤의 제조하되 (S)-카르니틴 내부염을 불활성용매에 녹인 다음, 반응용액을 100~190℃에서 0.5~5시간 방치한 후, 감압증류시키는 것을 특징으로 하는 다음 구조식(Ⅰ)로 표시되는 (S)-β-하이드록시-γ-부티로락톤의 제조방법.
- 다음 반응식에 의해 (S)-카르니틴을 직접 전환시켜 다음 구조식(Ⅰ)로 표시되는 (S)-β-하이드록시-γ-부티로락톤을 제조하되 (S)-카르니틴염과 동물량(equimolar amount)의 염기를 불활성용매에 녹인 다음, 반응용액을 100~190℃에서 0.5~5시간 후, 감압증류시키는 것을 특징으로 하는 다음 구조식(Ⅰ)로 표시되는 (S)-β-하이드록시-γ-부티로락톤의 제조방법.상기 식에서 X-는 특정 음이온이다.
- 제2항에 있어서, 상기 염기(base)로는 NaHCO3, NaOH 및 Et3N 중에서 선택된 것을 사용하는 것을 특징으로 하는 (S)-β-하이드록시-γ-부티로락톤의 제조방법.
- 제1항 또는 제2항에 있어서, 상기 용매로는 DMSO 및 DMF 중에서 선택된 비양성자성의 이중극성용매(anaprotic dipolar solvent)를 사용하는 것을 특징으로 하는 (S)-β-하이드록시-γ-부티로락톤의 제조방법.
- 제1항 또는 제2항에 있어서, 상기 용매로서 CH3CN/H2O 혼합용매를 사용하고, 80℃ 내지 용액의 환류온도에서 1~7일동안 반응시키는 것을 특징으로 하는 (S)-β-하이드록시-γ-부티로락톤의 제조방법.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITRM95A000652 | 1995-09-29 | ||
IT95RM000652A IT1276207B1 (it) | 1995-09-29 | 1995-09-29 | Procedimento per la preparazione del (s)-b-idrossi-gamma- butirrolattone |
Publications (2)
Publication Number | Publication Date |
---|---|
KR970015583A true KR970015583A (ko) | 1997-04-28 |
KR100407645B1 KR100407645B1 (ko) | 2004-03-18 |
Family
ID=11403592
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019960029667A KR100407645B1 (ko) | 1995-09-29 | 1996-07-23 | (S)-β-하이드록시-γ-부티로락톤의제조방법 |
Country Status (12)
Country | Link |
---|---|
US (1) | US5714619A (ko) |
EP (1) | EP0765876B1 (ko) |
JP (1) | JP4012588B2 (ko) |
KR (1) | KR100407645B1 (ko) |
AT (1) | ATE174333T1 (ko) |
CA (1) | CA2181012A1 (ko) |
DE (1) | DE69601116T2 (ko) |
DK (1) | DK0765876T3 (ko) |
ES (1) | ES2126969T3 (ko) |
GR (1) | GR3029537T3 (ko) |
IT (1) | IT1276207B1 (ko) |
ZA (1) | ZA968127B (ko) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20000065995A (ko) * | 1999-04-12 | 2000-11-15 | 박영구 | 키랄 3-히드록시-γ-부티로락톤의 제조방법 |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1297120B1 (it) * | 1997-12-16 | 1999-08-03 | Sigma Tau Ind Farmaceuti | Procedimento per la produzione di (r)-3-idrossi-4-butirrolattone utile nella preparazione della (r)-carnitina |
US7183423B1 (en) | 1998-12-11 | 2007-02-27 | Daicel Chemical Industries, Ltd. | Process for the preparation of organic compounds with imide catalysts |
CN104961711B (zh) * | 2015-07-23 | 2017-03-08 | 沧州那瑞化学科技有限公司 | (s)‑3‑羟基四氢呋喃和(r)‑3‑羟基四氢呋喃的制备方法 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3087325B2 (ja) * | 1991-02-21 | 2000-09-11 | チッソ株式会社 | 光学活性化合物とその製造法 |
IT1256705B (it) * | 1992-12-21 | 1995-12-12 | Sigma Tau Ind Farmaceuti | Procedimento per la preparazione di l-(-)-carnitina a partire da un prodotto di scarto avente opposta configurazione. |
IT1261230B (it) * | 1993-04-08 | 1996-05-09 | Sigma Tau Ind Farmaceuti | Procedimento migliorato per la preparazione di l-(-)-carnitina a partire da suoi precursori aventi opposta configurazione. |
IT1261231B (it) * | 1993-04-08 | 1996-05-09 | Sigma Tau Ind Farmaceuti | Procedimento migliorato per la preparazione di l-(-)-carnitina a partire da un prodotto di scarto avente opposta configurazione. |
IT1261489B (it) * | 1993-07-29 | 1996-05-23 | Sigma Tau Ind Farmaceuti | Procedimento per la produzione di r amminocarnitina e s amminocarnitina. |
US5473104A (en) * | 1994-09-13 | 1995-12-05 | Neurocrine Biosciences, Inc. | Process for the preparation of L-carnitine |
-
1995
- 1995-09-29 IT IT95RM000652A patent/IT1276207B1/it active IP Right Grant
-
1996
- 1996-07-11 US US08/678,684 patent/US5714619A/en not_active Expired - Fee Related
- 1996-07-11 CA CA002181012A patent/CA2181012A1/en not_active Abandoned
- 1996-07-18 ES ES96111567T patent/ES2126969T3/es not_active Expired - Lifetime
- 1996-07-18 DK DK96111567T patent/DK0765876T3/da active
- 1996-07-18 DE DE69601116T patent/DE69601116T2/de not_active Expired - Fee Related
- 1996-07-18 EP EP96111567A patent/EP0765876B1/en not_active Expired - Lifetime
- 1996-07-18 AT AT96111567T patent/ATE174333T1/de not_active IP Right Cessation
- 1996-07-23 KR KR1019960029667A patent/KR100407645B1/ko not_active IP Right Cessation
- 1996-08-01 JP JP20355396A patent/JP4012588B2/ja not_active Expired - Fee Related
- 1996-09-27 ZA ZA968127A patent/ZA968127B/xx unknown
-
1999
- 1999-03-01 GR GR990400632T patent/GR3029537T3/el unknown
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20000065995A (ko) * | 1999-04-12 | 2000-11-15 | 박영구 | 키랄 3-히드록시-γ-부티로락톤의 제조방법 |
Also Published As
Publication number | Publication date |
---|---|
DE69601116T2 (de) | 1999-05-06 |
EP0765876A1 (en) | 1997-04-02 |
GR3029537T3 (en) | 1999-06-30 |
JP4012588B2 (ja) | 2007-11-21 |
DE69601116D1 (de) | 1999-01-21 |
US5714619A (en) | 1998-02-03 |
JPH09110851A (ja) | 1997-04-28 |
KR100407645B1 (ko) | 2004-03-18 |
ITRM950652A1 (it) | 1997-03-29 |
ZA968127B (en) | 1997-04-21 |
ATE174333T1 (de) | 1998-12-15 |
DK0765876T3 (da) | 1999-08-16 |
IT1276207B1 (it) | 1997-10-27 |
ES2126969T3 (es) | 1999-04-01 |
ITRM950652A0 (ko) | 1995-09-29 |
EP0765876B1 (en) | 1998-12-09 |
CA2181012A1 (en) | 1997-03-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR920701104A (ko) | α, β-불포화 케톤의 제조방법 | |
KR860003215A (ko) | 4-페닐피롤 유도체의 제조방법 | |
KR960034176A (ko) | ε-카프로락탐 및 ε-카프로락탐 전구체의 제조방법 | |
KR890011904A (ko) | 안드로스타-1,4, -디엔-3,17-디온의 6-메틸렌 유도체 합성방법 | |
KR970015583A (ko) | (S) -β-하이드록시-γ-부티로락톤의 제조방법 | |
KR970701688A (ko) | 에폭사이드로부터 시스-1-아미노-2-알칸올을 제조하는 부분특이적 방법 (Regiospecific process to make cis-1-amino-2-alkanol from epoxide) | |
KR100362706B1 (ko) | 인듐을 이용하여 니트로기를 아민기로 환원시키는 방법 | |
EP0110202B1 (de) | Verfahren zur Herstellung von Phenylethanolaminen | |
ES483249A1 (es) | Procedimiento para la obtencion de diciclopentilen(2,2'-bis (4-alquil-6-t-butilfenoles). | |
JPH03261741A (ja) | 4―フェニル―3―ブテン―2―オンの製造法 | |
KR930009994A (ko) | 3-펜옥시-1-아제티딘카복스아미드를 합성하는 우레아융합법 | |
JPH0753483A (ja) | アミノプロピオン酸エステル誘導体の製法 | |
ATE129231T1 (de) | Verfahren zur herstellung von optisch aktiven norbornylaminderivaten. | |
KR960700232A (ko) | 신규시클로프로필유도체, 그 제조방법 및 용도(new cyclopropyl deri vatives, preparation method thereof and applications) | |
KR870011102A (ko) | 치환된 안트라〔1,9-cd〕피라졸-6(2H)-온 제조의 개선된 방법 | |
Datta et al. | Chiral β-C-lithiated β-alkoxy acrylates: Efficient synthons for highly functionalized cyclopentenones | |
HU201909B (en) | New process for producing substituted guanyl-thio-ureas | |
CN117658866A (zh) | 一种叠氮氨基酸衍生物的合成方法 | |
JP3079263B1 (ja) | オキソ化合物の製造方法 | |
ATE155125T1 (de) | Herstellung von dobutamin verbindungen | |
KR980002059A (ko) | 실릴알킬화 페로센 유도체 및 그들의 제조방법 | |
KR960017633A (ko) | 4-아미노페닐-2-아세톡시에틸설폰의 제조방법 | |
EP0619294A4 (en) | PROCESS FOR THE PRODUCTION OF 1-PHENOXY-2-AMINOPROPANE. | |
LU86785A1 (fr) | Procede de preparation d'encainide | |
KR940014361A (ko) | 4,5-디클로로-2-메틸-4-이소티아졸린-3-온의 제조방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20061113 Year of fee payment: 4 |
|
LAPS | Lapse due to unpaid annual fee |